News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
PrEP science
Sticker Shock: PrEP Is Not Cost-Effective at Current Price, Health Economists Find

For years, the U.S. HIV prevention community has known that pre-exposure prophylaxis (PrEP) is prohibitively expensive for many patients who need it. Now, new research presented at the 2019 National HIV Prevention Conference (NHPC) in Atlanta finds that not only is PrEP expensive for individual patients, it's also not cost-effective for the health system as a whole.

Published
09 April 2019
From
The Body
PrEP policies and guidelines
Councils seek NHS funding to cover drug trial pressures

London councils seeking “additional funding” from NHS England to help cover costs of PrEP trial places. Thousands of trial places at risk unless NHS provides around £3.5m. Fifteen MPs and Lords’ members have written to Matt Hancock to demand “sustainable solution”

Published
27 March 2019
From
Health Service Journal
Finance and funding
Project Inform expected to close

Project Inform, one of the nation's longest-running HIV education and advocacy organizations, has terminated its staff and is likely to cease operations, the Bay Area Reporter has learned.

Published
15 March 2019
From
Bay Area Reporter
Finance and funding
Trump Budget Proposes Largest Ever Cuts to Global HIV Programs

Just one month ago, President Trump promised during the State of the Union Address to defeat HIV in the U.S. and beyond. But the president’s budget proposal to Congress today—which threatens to gut life-saving HIV treatment and prevention programs—unmasks his lies. If implemented, Trump’s proposal would wipe out years of progress in the effort to end the AIDS pandemic.

Published
14 March 2019
From
Health GAP
Government, leadership and policy
Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle.

Published
14 March 2019
From
The New York Times
Finance and funding
TAG statement on the President’s FY 2020 budget proposal

Treatment Action Group (TAG) opposes the President’s Fiscal Year (FY) 2020 budget proposal, which makes a mockery of the administration’s purported strategy to end AIDS in the United States over the next decade. TAG welcomes additional investments in HIV prevention and treatment towards eliminating HIV in the U.S. However, the federal budget’s defunding equally important areas across domestic and global health programs, social services, and research raises tremendous doubt about the administration’s commitment to end HIV. We are also concerned about the fate of related epidemics such as hepatitis C (HCV) and tuberculosis (TB).

Published
14 March 2019
From
TAG
Finance and funding
Five National HIV Groups Weigh In on Trump’s 2020 Budget Proposal

The following is a statement from the Partnership to End HIV, STDs, and Hepatitis on President Trump’s A Budget for a Better America.

Published
12 March 2019
From
POZ
PrEP policies and guidelines
Sadiq Khan: Cash row is denying Londoners access to HIV ‘wonder drug’

The London mayor said: “I’m shocked that the Government is failing to provide local authorities in London with the funding they need to provide PrEP to all those who could benefit.”

Published
12 March 2019
From
Evening Standard
Finance and funding
Trump’s Budget Offers $291M To Fight HIV In U.S. But Trims Overseas Efforts

The Trump administration took another step toward fulfilling its goal of ending the HIV epidemic in the United States Monday by requesting $291 million for its initiative in the White House’s annual budget. But within the budget, the administration also proposed actions that could undermine efforts to control the virus’s spread, HIV experts and advocates said, including carving out funds from programs that aim to eradicate HIV in other parts of the world.

Published
12 March 2019
From
Kaiser Health News
Finance and funding
Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

Dozens of patient advocacy groups, like the Bonnie J. Addario Lung Cancer Foundation and the National Coalition for Cancer Survivorship, recently appeared in national advertisements objecting to a Trump administration proposal that could limit drugs covered by Medicare providers. But a Kaiser Health News analysis found that about half of the groups representing patients have received funding from the pharmaceutical industry.

Published
05 March 2019
From
Kaiser Health News
← Prev1...23456...118Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.